← Leaderboards
Laura McNay
Leidos Biomedical Research, Inc.
$15,147,252
Attributed
$15,147,252
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$15,147,252 · 1
By mechanism
N01$15,147,252 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Ethan Dmitrovsky$597,515,186
- Leonard Freedman$1,216,107,431
- Beth Baseler$335,223,481
- John Otridge$12,071,178
Others in their field
Other Emerging Leaders on “Blinded”
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Susan Abushakra · Alzheon, Inc.$51,190,244
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$36,614,885
- Yunda Huang · Fred Hutchinson Cancer Center$18,031,840
- Andrew S Huhn · Johns Hopkins University$17,756,243
Research focus
BlindedClinical TrialsCoronavirus DiseaseCovid-19Covid-19 PatientCovid-19 VaccinationDesignDropsHospitalizationImmune ResponseInfrastructureInjectionsInpatientsIntentionInvestigationMessenger RnaNew AgentsOutpatientsPlacebosProtocols DocumentationRandomizedRecoverySars-Cov-2 InfectionSeverity Of Illness